InSyBio is a biotechnology pioneer company (www.insybio.com) in personalized healthcare and nutrition which focuses on developing computational frameworks and tools for the analysis of complex life-science and biological data. The key objective of our analysis lies in discovering predictive integrated biosignatures (biomarkers of various categories) and models with increased prognostic and diagnostic aspects for personalized Healthcare and Nutrition Industries.
InSyBio has recently expanded its offering including a complete set of services that allows the personalization of nutrition, nutraceutical, vitamin and probiotic products. These services are built around InSyBio Personalization Test which allows predicting outcomes and satisfaction of each customer using specific products before even they purchase them.
InSyBio has developed an online suite of software tools – called InSyBio Suite – which assists biology researchers in extracting valuable biological knowledge from experimental data. The 3 and 12-month licenses of the InSyBio Suite as well as free 1-month licenses of our platform are provided.
InSyBio Suite consists of tools for providing integrated biological information from various sources, while at the same time it is empowered with robust, user-friendly and installation-free bioinformatics tools based on intelligent algorithms and methods. Some of its methodologies have already been published in international scientific journals and conferences while others are under submission for patent approval by its members. The use of InSyBio Suite for biomedical data analyses, reduces the time and cost requirements by at least 80%, increases predictive accuracy of outcome and diagnostic predictive models by at least 10% and allows biomarker and outcome models discovery in low sample size studies.
Since June 2015 InSyBio participates in NBG Business Seeds program by National Bank of Greece.
For more information about our company contact us at info@insybio.com.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 2101 E. St. Elm, Bldg. 1,ste. 100,med2market Offices,united Kingdom
- in****@****ybio.gr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- insybio.com
- Keywords
- Bioinformatics, Systems Medicine, Biomarkers Discovery, Gene Expression Data Analysis, Proteomics, Personalizednutrition, MachineLearning, ArtificialIntelligence.
- HQ
- Austin, Texas
Insybio Questions
Insybio's website is insybio.com
Insybio's LinkedIn profile is https://www.linkedin.com/company/insybio
Insybio has
8 employees.
View email and phone details for 8
employees at Insybio.
Insybio's industry is
Biotechnology Research
Insybio's top competitors are
Cilcare,
Mt-Act,
Seqone,
Sthenos Ai,
Mycea,
Azelead,
Innovative Diagnostics,
Acobiom,
Stem Genomics,
Enpicom.
Insybio's support email address is info@insybio.gr
Insybio's categories are Biotechnology Research
Insybio's founding year is 2013
